Retrograde scientometric analysis of the scientific impact of cystic fibrosis

S. Falahkohan, D. Groneberg, C. Scutaru, A. Fischer, D. Quarcoo, B. Kloft (Berlin, Germany)

Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects
Session: Cystic fibrosis: a disease with many aspects
Session type: Thematic Poster Session
Number: 1255
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Falahkohan, D. Groneberg, C. Scutaru, A. Fischer, D. Quarcoo, B. Kloft (Berlin, Germany). Retrograde scientometric analysis of the scientific impact of cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 1255

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012


Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis
Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
Year: 2017



Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Year: 2020



Recent developments in the management of Cystic fibrosis
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017


The role of imagistic and functional methods in severity evaluation in children with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis: better diagnosis, improved progress, but long-term complications
Year: 2007


Inflammation, age and changing microbiology: the search for causation in the cystic fibrosis airways
Source: Eur Respir J, 50 (5) 1701935; 10.1183/13993003.01935-2017
Year: 2017



Case study in cystic fibrosis: the US CF Foundation research and clinical development programmes
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014


Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Source: Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021
Year: 2021



Practical microbiology of cystic fibrosis lung disease
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Global impact of bronchiectasis and cystic fibrosis
Source: Breathe 2016; 12: 222-235
Year: 2016



Update on new treatments for cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020


A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021


The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021
Year: 2021



Improved turn around time for molecular genetic analysis for cystic fibrosis: The Irish experience
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011

The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014


Psychosocial aspects of cystic fibrosis
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

The German cystic fibrosis quality assurance project: clinical features in children and adults
Source: Eur Respir J 2001; 17: 1187-1194
Year: 2001